Abstract
Multiple sclerosis (MS) is a common neurological disease in the Western hemisphere that leads to neurological dysfunctions and frequently from its onset to cognitive impairment, which together predict quality of life. Recent pathological and imaging studies have focused on brain atrophy representing axonal injury and loss as being crucial for developing disability and neuropsychological impairment. Brain atrophy has therefore been proposed to be a tool for monitoring disease progress. Here, we review the possible origins of brain atrophy and its correlation with cognitive impairment in MS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amato MP, Bartolozzi ML, Zipoli V, Portaccio E et al. (2004) Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 63:89–93
Anderson VM, Fox NC, Miller DH (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 23:605–618
Babbe H, Roers A, Waisman A, Lassman H, Goebels N, Hohlfeld R et al. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 192:393–404
Benedict RH, Carone DA, Bakshi R (2004) Correlating brain atrophy with cognitive dysfunction,mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 14:36–45
Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R (2004) Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 61:226–230
Benedict RHB, Bakshi R, Simon JH, Priore R, Miller C et al. (2002) Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 14:44–51
Bermel RA, Bakshi, R, Tjoa C, Puli SR, Jacobs L (2002) Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 59:275–280
Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8:43–77
Brück W (2005) Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J Neurol 252:10–15
Christodoulou C, Krupp LB, Liang Z, Huang W, Melville P et al. (2003) Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 60:1793–1798
Deloire MSA. Salort E, Bonnet M, Arimone Y, Boudineau M et al. (2005) Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76:519–526
Edwards SGM, Liu C, Blumhardt LD (2001) Cognitive correlates of supratentorial atrophy on MRI in multiple sclerosis. Acta Neurol Scand 104:214–223
Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123:1845–1849
Hildebrandt H, Hahn HK, Kraus JA, Schulte-Herbrüggen A, Schwarze B, Schwendemann G (2006) Memory performance in MS patients correlates with central brain atrophy. Mult Scler 12:428–436
Hildebrandt H, Lanz M, Hahn HK, Hoffmann E, Schwarze B, Schwendemann G, Kraus JK (2007) Cognitive training in MS: Effects and relation to brain atrophy. Restor Neurol Neurosci (in press)
Hildebrandt H, Schwendemann G (2004) Kognitive Beeinträchtigungen bei Multipler Sklerose. In: Zieger A, Schönle P (ed) Neurorehabilitation bei diffuser Hirnschädigung. Hippokampus, Bad Honnef, pp 237–278
Hohol MJ, Guttmann CRG, Orav J, Mackin GA, Kikinis R et al. (1997) Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 54:1018–1025
Kalkers NF, Bergers E, Castelijns JA, van Waldervee M et al. (2000) Optimizing the association between disability and biological markers in MS. Neurology 57:1253–1258
Kutzelnigg A, Lucchinetti C, Stadelmann C et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705–2712
Lazeron RHC, Boringa JB, Schouten M et al. (2005) Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 11:524–531
Lukas C, Hahn HK, Bellenberg B et al. (2004) Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis. Neuroradiology 46:906–915
Oh J, Pelletier D, Nelson SJ (2004) Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging. Arch Neurol 7:1081–1086
Paollilo A, Piatella MC, Pantano P et al. (2004) The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple dose gadolinium-DTPA J Neurol 251:432–439
Pelletier D, Nelson SJ, Oh J, Antel JP, Kita M, Zamvil SS et al. (2003) MRI lesion volume heterogeneity in primary progressive multiple sclerosis in relation with axonal damage and brain atrophy. J Neurol Neurosurg Psychiatry 74:950–952
Piras MR, Magnano I, Canu E, Paulus K, SattaW, Conti M et al. (2003) Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 74:878–885
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0901-z.
Rights and permissions
About this article
Cite this article
Lanz, M., Hahn, H.K. & Hildebrandt, H. Brain atrophy and cognitive impairment in multiple sclerosis: a review. J Neurol 254 (Suppl 2), II43–II48 (2007). https://doi.org/10.1007/s00415-007-2011-8
Issue Date:
DOI: https://doi.org/10.1007/s00415-007-2011-8